FDA DTC Report Calls For Additional Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency's summary of three surveys of patients and physicians shows mixed results as to the effects of DTC ads on patient-physician relationships. The report finds a drop in consumers' opinion of DTC ads over three years.
You may also be interested in...
FDA Revises Prescriber DTC Survey To Focus On Patient Interactions
The agency appeared unusually receptive to outside suggestions about a proposed questionnaire, dropping questions related to drug pricing and adding ones about exam room conversations.
DTC Decennial Survey: FDA Adds Nurses, Physician Assistants To Queries On Ads
The survey will update findings from a 2002 assessment by physicians on the impact of DTC marketing on their interactions with patients.
DTC Ad Comparative Claims Draw FDA Criticism, Even With “Scientific Basis”
“We’re not pleased with the way direct-to-consumer advertising is going,” Acting Commissioner Crawford says. DTC ads have become “ridiculous,” he says; “very strong measures” by FDA may be warranted.